Trioar

Developer of drugs for the treatment of cancer

placeYuseong District, Hoseo, South Korea calendar_todayFounded 2021 groups16 employees language trioar.co.kr

Innovation

5 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 132 times.

YearFilings
20243
20255
20261

Investor mix

13 investors on record.

Investor typeCountShare
Venture capital969%
Private equity215%
Bank & private debt18%
Other / undisclosed18%
Coming soon